REAP - a Photonics PPP project

Funded by the Horizon 2020 framework (Call: Information and Communication Technologies, Disruptive Photonics Technology), the European consortium for REAP consists of 9 multidisciplinary teams from academia, research institute and industry spanning areas of expertise in biology, material science, oncology, chemistry, photonics, electrical and biomedical engineering. In order to benefit from external input, representatives from industry, academia, and health care institutes form an advisory board providing feedback on improvements and adjustments to the project. Efforts will be intertwined to spear head developments of microscopy and tomography multimodal imaging systems to provide a platform revealing drug tolerant persister cells in breast cancer in a preclinical setting. www.projectREAP.eu https://cordis.europa.eu/project/id/101016964/de